| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.2B | $1.1B | $1.1B | $1.3B | $1.3B | $1.1B | $0.2B | $0.2B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.1B | $0.1B | $0.1B | $0.2B | $0.3B | $0.2B | $0.0B | $0.0B |
| EPS (Basic) | $1.65 | $3.19 | $3.20 | $6.43 | $8.27 | $7.85 | $1.38 | $1.47 |
| EPS (Diluted) | $1.64 | $3.19 | $3.18 | $6.36 | $8.15 | $7.69 | $1.34 | $1.41 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $5.1B | $4.4B | $4.1B | $4.0B | $5.2B | $4.7B | $2.7B | $2.8B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.3B | $0.3B | $0.3B | $0.2B | $0.3B | $0.3B | $0.1B | $0.1B |
| Total Liabilities | $3.3B | $2.6B | $2.3B | $2.3B | $3.6B | $3.5B | $1.6B | $1.9B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $1.7B | $1.7B | $1.7B | $1.7B | $1.6B | $1.2B | $1.0B | $0.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $-0.7B | $0.1B | $-0.0B | $1.6B | $0.9B | $-1.4B | $0.4B | $0.1B |
| Investing Cash Flow | $-0.1B | $-0.0B | $0.1B | $-0.1B | $-0.4B | $0.1B | $-0.1B | $-0.6B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $0.8B | $-0.2B | $0.0B | $-1.6B | $-0.5B | $1.5B | $-0.3B | $0.3B |